MARKET

AXSM

AXSM

Axsome Therapeut
NASDAQ
156.57
-7.70
-4.68%
Opening 12:33 03/27 EDT
OPEN
163.89
PREV CLOSE
164.27
HIGH
163.89
LOW
156.11
VOLUME
316.28K
TURNOVER
--
52 WEEK HIGH
191.50
52 WEEK LOW
86.99
MARKET CAP
8.01B
P/E (TTM)
-42.5219
1D
5D
1M
3M
1Y
5Y
1D
Axsome Therapeutics Is Maintained at Buy by Guggenheim
Dow Jones · 2d ago
Guggenheim Maintains Buy on Axsome Therapeutics, Raises Price Target to $245
Benzinga · 2d ago
Guggenheim Keeps Their Buy Rating on Axsome Therapeutics (AXSM)
TipRanks · 2d ago
Axsome Therapeutics price target raised to $245 from $220 at Guggenheim
TipRanks · 2d ago
Weekly Report: what happened at AXSM last week (0316-0320)?
Weekly Report · 4d ago
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Monte Rosa Therapeutics (GLUE) and Curis (CRIS)
TipRanks · 5d ago
Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Axsome Therapeutics (AXSM)
TipRanks · 03/18 20:40
3 Best Growth Stocks to Buy This Week, According to Analysts – March 16-20
TipRanks · 03/16 21:38
More
About AXSM
Axsome Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for people living with central nervous system (CNS) conditions. The Company's commercial products include Auvelity, Sunosi and Symbravo. It is also advancing a diversified, late-stage pipeline of product candidates for serious neurological and psychiatric conditions, which include AXS-05, AXS-12, AXS-14 and AXS-17. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder (MDD). Sunosi (solriamfetol) is an oral medication indicated for the treatment of excessive daytime sleepiness (EDS), in patients with narcolepsy or obstructive sleep apnea. Symbravo (meloxicam and rizatriptan, 20 mg/10mg tablets) is an oral, single-dose medicine approved for the acute treatment of migraine with or without aura in adults.

Webull offers Axsome Therapeutics Inc stock information, including NASDAQ: AXSM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXSM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AXSM stock methods without spending real money on the virtual paper trading platform.